Personalized vs Standardized Self-Management Training for Colorectal Cancer
Trial Summary
What is the purpose of this trial?
This is a Phase 2 prospective, randomized, controlled, double-arm study to assess personalized self-management training (PSMT) intervention efficacy and patient experiences compared to standardized self-management training (SSMT). A total of 120 colorectal cancer (CRC) patients will be enrolled and randomized 1:1 to complete a 6-week self-management training program (either PSMT or SSMT) to be carried out by licensed occupational therapists with doctoral training. This study aims to examine whether PSMT is more effective in increasing adherence to healthy behavior recommendations compared to SSMT in CRC patients.
Will I have to stop taking my current medications?
The trial does not specify whether you need to stop taking your current medications. However, long-term hormonal or biologic therapy is acceptable, so you may be able to continue those treatments.
What data supports the effectiveness of Personalized and Standardized Self-Management Training for Colorectal Cancer?
Is self-management training safe for colorectal cancer patients?
How does the Personalized vs Standardized Self-Management Training treatment for colorectal cancer differ from other treatments?
This treatment is unique because it focuses on self-management training, which empowers patients to take an active role in managing their condition. Unlike traditional treatments that may focus solely on medical interventions, this approach includes personalized or standardized training to help patients manage their health and improve their quality of life.110111213
Research Team
Alix G. Sleight, PhD, OTD, MPH, OTR/L
Principal Investigator
Cedars-Sinai Medical Center
Eligibility Criteria
This trial is for adults over 18 who've had Stage I-III colorectal cancer in the last year, are willing to improve at least one lifestyle risk factor like diet or exercise, and can speak English. They should have moderate to low adherence to healthy behaviors but can't be planning major cancer treatments within 6 months or have stage IV cancers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 6-week self-management training program, either personalized (PSMT) or standardized (SSMT), conducted by licensed occupational therapists
Follow-up
Participants are monitored for adherence to healthy behavior recommendations and quality of life assessments
Treatment Details
Interventions
- Personalized Self-Management Training
- Standardized Self-Management Training
Find a Clinic Near You
Who Is Running the Clinical Trial?
Arash Asher, MD
Lead Sponsor
Alix G. Sleight, PhD
Lead Sponsor
National Institutes of Health (NIH)
Collaborator
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator